益气缓哮汤治疗儿童支气管哮喘慢性持续期的临床研究

摘要/Abstract

摘要： 目的通过观察益气缓哮汤治疗儿童支气管哮喘慢性持续期的临床疗效，探讨其有效性。方法选择2018年1月至2020年1月我院收治的支气管哮喘慢性持续期气虚痰结证患儿120例，随机分为观察组和对照组各60例。对照组给予雾化吸入布地奈德联合孟鲁司特钠咀嚼片治疗。观察组给予益气缓哮汤治疗。记录并比较两组患儿治疗前后哮喘症状积分、哮喘控制测试问卷(C-ACT)评分、肺功能指标、血清免疫球蛋白水平、肺部高分辨率CT马赛克征评分，并进行统计。结果观察组、对照组各脱落7例。观察组总有效率为94.34%(50/53),高于对照组81.14%(43/53),差异有统计学意义(P<0.05)。两组患儿哮喘症状积分、C-ACT评分、第1秒用力呼气量占用力肺活量比值(FEV1/FVC)指标、血清免疫球蛋白IgA、IgG、IgM水平、肺部高分辨率CT马赛克征评分均较治疗前明显降低，且观察组明显低于对照组，差异有统计学意义(P<0.05)。结论益气缓哮汤治疗儿童支气管哮喘慢性持续期优于传统西药治疗，具有临床推广价值。

关键词: 支气管哮喘, 慢性持续期, 气虚痰结证, 儿童

Abstract: ObjectiveTo observe the clinical effect of Yiqi Huanxiao decoction on bronchial asthma at chronic persistent phase in children and to explore its effectiveness.MethodsTotally 120 children with chronic persistent Qi-deficiency and phlegm-stasis syndrome of bronchial asthma were randomly divided into experimental group and control group,with 60 in each group.The control group was treated with nebulized budesonide combined with montelukast sodium chewable tablets.The experimental group was treated with Yiqi Huanxiao decoction.Record and compare asthma symptom score,C-ACT score,lung function index,serum immunoglobulin level,lung HRCT mosaic sign score,and carry out the statistical analysis.ResultsThere were 7 cases in each group which were lost to follow.The total effective rate in the experimental group was 94.34%(50/53),higher than that in the control group (81.14%,43/53),and the difference was of statistical significance (P<0.05).The asthma symptom score,C-ACT score,FEV1/FVC index,serum immunoglobulin IgA,IgG and IgM level,and lung HRCT mosaic score were significantly lower than those before treatment,and the experimental group was significantly lower than the control group,the difference being statistically significant (P<0.05).ConclusionThe treatment with Yiqi Huanxiao decoction for bronchial asthma at chronic persistent phase in children is superior to traditional western medicine,which has clinical popularization value.

Key words:

Bronchial asthma, Chronic persistent phase, Qi-deficiency and phlegm-stasis syndrome, Children

李东楠, 王海, 邢鑫鑫, 刘博男, 王圣楠. 益气缓哮汤治疗儿童支气管哮喘慢性持续期的临床研究[J]. 中国中西医结合儿科学, 2022, 14(1): 16-20.

LI Dongnan, WANG Hai, XING Xinxin, LIU Bonan, WANG Shengnan.

Clinical study on treating bronchial asthma at chronic persistent phase in children with Yiqi Huanxiao decoction [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(1): 16-20.

[1]	罗小平, 吴薇. 关注矮身材儿童的规范化诊疗[J]. 中国中西医结合儿科学, 2024, 16(5): 369-371.
[2]	俞建, 王纳, . 矮身材的中西医结合研究及展望[J]. 中国中西医结合儿科学, 2024, 16(5): 372-376.
[3]	王力宁, 孙克兴, 梁艺, . 中医外治法在儿童生长发育中的应用[J]. 中国中西医结合儿科学, 2024, 16(5): 384-387.
[4]	董丹, 李滢, 王雪峰, . 基于“脾统四脏”理论以“滋生健脾法”辨治儿童矮身材探析[J]. 中国中西医结合儿科学, 2024, 16(5): 387-391.
[5]	童婷婷, 张桂菊, . 基于“阳化气，阴成形”论治儿童矮身材[J]. 中国中西医结合儿科学, 2024, 16(5): 392-394.
[6]	冯忠发, 杨见辉, 粟艳艳, 魏家璇, 陶琼, 杜丽, . 浅谈万全“育婴四法”对小儿生长发育的影响[J]. 中国中西医结合儿科学, 2024, 16(5): 395-398.
[7]	刘文, 关丽君, . 中医外治法治疗儿童睡眠障碍研究进展[J]. 中国中西医结合儿科学, 2024, 16(5): 410-413.
[8]	徐浩繁, 钟增泉, 赖燕媚, 李威, 张欣, 历虹, 杨帆, 李翌鸣, 吕智海, . 婴幼儿肌张力低下的康复评估与治疗进展[J]. 中国中西医结合儿科学, 2024, 16(5): 414-419.
[9]	王格, 张雪荣, 刘雁云, 段云雁, 沈鹤霄, . 中枢性性早熟女童肠道菌群分析[J]. 中国中西医结合儿科学, 2024, 16(5): 419-424.
[10]	吴依师, 张秀英, 李兆洋, 王雪峰, . 中医药联合重组人生长激素治疗儿童特发性矮小症的Meta分析[J]. 中国中西医结合儿科学, 2024, 16(5): 425-430.
[11]	瞿圣岳, 穆婧雯, 杨建树, 赵航宇, 张秀英, 王雪峰, . 小儿咳喘灵口服液(浓缩型)治疗儿童肺炎支原体肺炎的临床疗效观察[J]. 中国中西医结合儿科学, 2024, 16(5): 431-435.
[12]	全卉, 宋青青, 易青梅, . 川崎病患儿并发冠脉损伤的预测模型构建[J]. 中国中西医结合儿科学, 2024, 16(5): 436-439.
[13]	姚奕屹, 朱义, 陈政, 杜真, . 小剂量艾司氯胺酮预先注射减轻小儿丙泊酚中/长链脂肪乳注射痛[J]. 中国中西医结合儿科学, 2024, 16(5): 440-444.
[14]	马晓丹, 高文丽, 王娇娇, . 豉翘清热颗粒联合头孢呋辛治疗小儿急性呼吸道感染的效果及对炎症因子的影响[J]. 中国中西医结合儿科学, 2024, 16(5): 444-448.
[15]	许佳烨, 程申, 杨育访, 陈玉燕, 李玲, 陈雅琴, 王晓鸣, . 基于数据挖掘探讨王晓鸣教授诊治小儿再发性腹痛规律研究[J]. 中国中西医结合儿科学, 2024, 16(5): 449-454.

益气缓哮汤治疗儿童支气管哮喘慢性持续期的临床研究

Clinical study on treating bronchial asthma at chronic persistent phase in children with Yiqi Huanxiao decoction

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价